Source: Fletcher/CSI Blog

Fletcher/CSI Blog Conference Summary: 2024 Pharma CI US

It was another exciting 2024 Pharma CI USA assembly! For our 17th year in attendance, Fletcher continued its role as a key legacy sponsor and session presenter. This year’s topic: Are Disruptors Disrupting Your Strategy?, was a walkthrough of some of the most significant industry disruptors and ways CI/MI practitioners better predict, adjust, and enhance strategies to stay competitive. READ MORE The post Conference Summary: 2024 Pharma CI US appeared first on Fletcher - Global Competitive Insights.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Erik Glitman's photo - CEO of Fletcher/CSI

CEO

Erik Glitman

CEO Approval Rating

54/100

Read more